Directorate Change

Tate & Lyle PLC
                  

Tate & Lyle Board Changes

Tate & Lyle PLC (the 'Company') announces that Stanley Musesengwa, Chief
Executive International and Stuart Strathdee, Corporate Development Director,
will retire from

Tate & Lyle's Board of Directors at the Company's Annual General Meeting ('AGM')
on 23 July 2008.

Stanley Musesengwa has worked for Tate & Lyle for over 28 years and has served
on the Board since April 2003. The Group's portfolio of businesses has been
significantly reshaped into four Divisions during the past two years and, as
expected, this process has led to Stanley's current position being phased out.
As a result, it has been agreed with Stanley that he will stand down from the
Board of Directors and leave Tate & Lyle at the AGM on 23 July 2008 to develop
further his portfolio of interests.

In the period from now until the AGM in July, Stanley Musesengwa will assist in
an orderly transition of his responsibilities. Direct reporting line
responsibilities for Tate & Lyle's Sugars, Sucralose and Food & Industrial
Ingredients, Europe Divisions will transfer to the Chief Executive from 1 July
2008.

Stuart Strathdee has worked for Tate & Lyle for over 31 years and has served on
the Board since November 1994. He was appointed to his current position as
Corporate Development Director in July 2003. After he stands down as a Director
at the AGM, he will remain with Tate & Lyle for a further year to assist the
Company with its strategic development before he retires at the end of July
2009.

Sir David Lees, Chairman of Tate & Lyle, said: 'Stanley Musesengwa has made an
enormous impact on Tate & Lyle. As Chief Operating Officer he led the Company's
operations with great skill during a time of significant change for the business
and in the past two years he has played a key role in developing and
implementing our streamlined organisational structure. I would like to thank him
for all he has done for Tate & Lyle and wish him every success in the future.

'Stuart Strathdee has been a key member of the executive team for a number of
years and has played a major role in driving the strategic direction of the
business. The Board is deeply appreciative of Stuart's loyal service as a
Director over the past 14 years and is delighted that Tate & Lyle will continue
to benefit from his considerable knowledge and expertise for a further year
after he stands down from the Board.'

Stanley Musesengwa said: 'I have thoroughly enjoyed my time at Tate & Lyle and
it has given me great satisfaction to be part of its development. I wish Iain
Ferguson and his team every success in the future as they continue to drive the
business forward.'
                                                        e PLC:

Ferne Hudson, Head of Media and Public Relations
Tel: [phone] or Mobile [phone]

Tim Lodge, Director of Investor Relations
Tel: [phone] or Mobile: [phone]
*T

Note to Editor

-0-
*T
1. Stanley Musesengwa's current portfolio of interests includes serving as a
   Non-Executive Director of Croda International plc and as a Trustee of the Eastside Young Leaders Academy.
*T

About Tate & Lyle:

Tate & Lyle is a world leading manufacturer of renewable food and industrial
ingredients. It uses innovative technology to transform corn and sugar into
value-added ingredients for customers in the food, beverage, pharmaceutical,
cosmetic, paper, packaging and building industries. The Company is a leader in
cereal sweeteners and starches, sugar refining, value added food and industrial
ingredients, and citric acid. Tate & Lyle is the world number-one in industrial
starches and is the sole manufacturer of SPLENDA(R) Sucralose.

Headquartered in London, Tate & Lyle is listed on the London Stock Exchange
under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company
operates more than 50 production facilities throughout Europe, the Americas and
South East Asia. In the year to 31 March 2007, it employed 6,900 people in its
subsidiaries with a further 2,300 employed in joint ventures. Sales in the year
to 31 March 2007 totalled £4.0 billion. Additional information can be found on
http://www.tateandlyle.com.

SPLENDA(R) is a trademark of McNeil Nutritionals, LLC